↓ Skip to main content
What is this page? Embed badge

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker…

Overview of attention for article published in BMC Cancer, June 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
82 Mendeley
Summary X Patents Dimensions citations
So far, Dimensions has found 58 publications that cite this research output.

58

The most recent citing publications are shown below. View all 58 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.